- Home
- KFRC vs QURE Comparison
KFRC vs QURE Comparison
Compare KFRC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFRC
- QURE
- Stock Information
- Founded
- KFRC 1962
- QURE 1998
- Country
- KFRC United States
- QURE Netherlands
- Employees
- KFRC N/A
- QURE N/A
- Industry
- KFRC Professional Services
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- KFRC Consumer Discretionary
- QURE Health Care
- Exchange
- KFRC Nasdaq
- QURE Nasdaq
- Market Cap
- KFRC 809.8M
- QURE 866.3M
- IPO Year
- KFRC 1995
- QURE 2007
- Fundamental
- Price
- KFRC $32.69
- QURE $16.01
- Analyst Decision
- KFRC Buy
- QURE Strong Buy
- Analyst Count
- KFRC 3
- QURE 10
- Target Price
- KFRC $52.33
- QURE $36.90
- AVG Volume (30 Days)
- KFRC 282.7K
- QURE 816.1K
- Earning Date
- KFRC 10-27-2025
- QURE 07-29-2025
- Dividend Yield
- KFRC 4.75%
- QURE N/A
- EPS Growth
- KFRC N/A
- QURE N/A
- EPS
- KFRC 2.39
- QURE N/A
- Revenue
- KFRC $1,361,445,000.00
- QURE $14,337,000.00
- Revenue This Year
- KFRC N/A
- QURE N/A
- Revenue Next Year
- KFRC $0.75
- QURE $278.91
- P/E Ratio
- KFRC $13.76
- QURE N/A
- Revenue Growth
- KFRC N/A
- QURE N/A
- 52 Week Low
- KFRC $30.44
- QURE $4.45
- 52 Week High
- KFRC $66.50
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- KFRC 41.12
- QURE 63.39
- Support Level
- KFRC $31.59
- QURE $15.28
- Resistance Level
- KFRC $32.95
- QURE $16.43
- Average True Range (ATR)
- KFRC 1.12
- QURE 0.83
- MACD
- KFRC 0.39
- QURE 0.12
- Stochastic Oscillator
- KFRC 60.85
- QURE 89.15
About KFRC Kforce Inc.
Kforce Inc is a solutions firm specializing in technology, finance and accounting, and other professional staffing services. The company operates two business segments: 1) In technology segment it provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) In FA segment company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.